Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Return on Invested Capital [ROIC] (2013 - 2026)

Updated

Elite Pharmaceuticals' Return on Invested Capital [ROIC] was 29.21% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 41.48 percentage points from 70.69% a year earlier and down 13.00 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Return on Invested Capital [ROIC] (2013 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Return on Invested Capital [ROIC] at Elite Pharmaceuticals came in at 49.40%, up 15.61 percentage points from FY2025.

  • Return on Invested Capital [ROIC] has now increased for three consecutive fiscal years, with a four-year change of +26.51 percentage points (FY2022 to FY2026).
  • In earlier fiscal years, Return on Invested Capital [ROIC] was 33.79% in FY2025 (+10.29 pp), 23.50% in FY2024 (+12.23 pp), 11.27% in FY2023 (-11.61 pp) and 22.88% in FY2022.
  • The fiscal Q1 2027 figure marks the lowest quarterly Return on Invested Capital [ROIC] since fiscal Q3 2025.
  • Compared with a year earlier, Return on Invested Capital [ROIC] was higher in seven of the last eight quarters, with an average year-over-year change of +14.29 percentage points.
  • The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was fiscal Q1 2026 (a gain of 49.12 percentage points); the worst was fiscal Q1 2027 (a drop of 41.48 percentage points).
  • Per Business Quant data, ELTP's Return on Invested Capital [ROIC] in the three fiscal quarters before Q1 2027 was 42.21% (Q4 2026), 53.66% (Q3 2026) and 43.21% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.57%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 18.68%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 3.56%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 34.87%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 23.26%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 14.33%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 13.44%
10 Elite Pharmaceuticals 269.28 Mn 150.96 Mn 13.51 Mn 29.19%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.19%
Mar 31, 2026 42.17%
Dec 31, 2025 53.59%
Sep 30, 2025 43.14%
Jun 30, 2025 70.54%
Mar 31, 2025 41.26%
Dec 31, 2024 27.38%
Sep 30, 2024 24.84%
Jun 30, 2024 21.53%
Mar 31, 2024 19.73%
Dec 31, 2023 0.00%
Sep 30, 2023 12.63%
Jun 30, 2023 11.62%
Mar 31, 2023 9.51%
Dec 31, 2022 11.21%
Sep 30, 2022 11.93%
Mar 31, 2022 19.87%
Dec 31, 2021 13.55%
Sep 30, 2021 10.88%
Dec 31, 2020 9.54%
API Access

Elite Pharmaceuticals Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY